查看文章

Pulmonary embolism (PE) is a major health issue, ranking as the third leading cause of death amongst cardiovascular diseases. 1 The management of PE can be complex and varies based on the risk stratification of the patients. The European Society of Cardiology (ESC) guidelines on the treatment of PE introduced a model that incorporates clinical and laboratory parameters, along with radiological signs, to categorize patients into four risk classes for early mortality. 2 The factors considered in this model include haemodynamic instability, an assessment of clinical parameters and medical history using the Pulmonary Embolism Severity Index (PESI) score, evidence of right ventricular (RV) dysfunction observed with transthoracic echocardiogram (TTE) or computed tomography pulmonary angiography (CTPA) scans, and laboratory findings like elevated troponin levels. According to this guideline, the clinical …